Last reviewed · How we verify

NCT03110718

Role of Armeo-Power and Muscle Vibration in Upper Limb Rehabilitation

Completed NA Last updated 12 April 2017
What this trial tests

NA trial testing ArmeoP+real MV in Stroke in 20 participants. Completed in 1 October 2015.

Timeline
2 January 2015
Primary endpoint
2 June 2015
1 October 2015

Quick facts

Lead sponsorIRCCS Centro Neurolesi Bonino Pulejo
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment20
Start date2 January 2015
Primary completion2 June 2015
Estimated completion1 October 2015

Drugs / interventions tested

Conditions studied

Sponsor

IRCCS Centro Neurolesi Bonino Pulejo — full company profile →

Who can join

Adults 18 to 80, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Muscle vibration (MV) has been suggested as a useful non-pharmacological approach to control spasticity. Armeo Power® (AP) is a robotic exoskeleton for rehabilitation allowing early rehabilitation treatment. The objective of our study was to determine whether AP training coupled with MV applied on antagonist muscles of the spastic upper limb (UL) can reduce the spasticity of agonist muscles. We enrolled 20 chronic post-stroke patients, who underwent 40 daily sessions of AP training. Ten subjects (group-A) received muscle MV (on triceps brachii, deltoid, and supraspinatus), whereas the other 10 (group-B) underwent a sham vibration.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Is two better than one? Muscle vibration plus robotic rehabilitation to improve upper limb spasticity and function: A pilot randomized controlled trial.
    Calabrò RS, Naro A, Russo M, Milardi D, et al · · 2017 · cited 48× · PMID 28973024 · DOI 10.1371/journal.pone.0185936

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other IRCCS Centro Neurolesi Bonino Pulejo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03110718.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing